GB0504950D0 - Organic compositions - Google Patents

Organic compositions

Info

Publication number
GB0504950D0
GB0504950D0 GBGB0504950.7A GB0504950A GB0504950D0 GB 0504950 D0 GB0504950 D0 GB 0504950D0 GB 0504950 A GB0504950 A GB 0504950A GB 0504950 D0 GB0504950 D0 GB 0504950D0
Authority
GB
United Kingdom
Prior art keywords
organic compositions
compositions
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0504950.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Priority to GBGB0504950.7A priority Critical patent/GB0504950D0/en
Publication of GB0504950D0 publication Critical patent/GB0504950D0/en
Priority to CNA2006800076288A priority patent/CN101137348A/zh
Priority to US11/908,216 priority patent/US20080279940A1/en
Priority to EP06723358A priority patent/EP1858484A1/en
Priority to BRPI0609023-0A priority patent/BRPI0609023A2/pt
Priority to EP10178526A priority patent/EP2305215A1/en
Priority to AU2006222117A priority patent/AU2006222117B2/en
Priority to JP2008500134A priority patent/JP2008532967A/ja
Priority to KR1020077020512A priority patent/KR20070117578A/ko
Priority to PCT/EP2006/002245 priority patent/WO2006094829A1/en
Priority to EP09151789A priority patent/EP2065033A1/en
Priority to RU2007137182/15A priority patent/RU2007137182A/ru
Priority to CA002599251A priority patent/CA2599251A1/en
Priority to MX2007011016A priority patent/MX2007011016A/es
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Biochemistry (AREA)
  • Otolaryngology (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GBGB0504950.7A 2005-03-10 2005-03-10 Organic compositions Ceased GB0504950D0 (en)

Priority Applications (14)

Application Number Priority Date Filing Date Title
GBGB0504950.7A GB0504950D0 (en) 2005-03-10 2005-03-10 Organic compositions
MX2007011016A MX2007011016A (es) 2005-03-10 2006-03-10 Microemulsiones de compuestos aglutinantes de receptores canabinoides.
AU2006222117A AU2006222117B2 (en) 2005-03-10 2006-03-10 Microemulsions of cannabinoid receptor binding compounds
KR1020077020512A KR20070117578A (ko) 2005-03-10 2006-03-10 칸나비노이드 수용체 결합 화합물의 마이크로에멀젼
EP06723358A EP1858484A1 (en) 2005-03-10 2006-03-10 Microemulsions of cannabinoid receptor binding compounds
BRPI0609023-0A BRPI0609023A2 (pt) 2005-03-10 2006-03-10 microemulsões de compostos de ligação a receptor canabinóide
EP10178526A EP2305215A1 (en) 2005-03-10 2006-03-10 Microemulsions of cannabinoid receptor binding compounds
CNA2006800076288A CN101137348A (zh) 2005-03-10 2006-03-10 大麻素受体结合性化合物的微乳液
JP2008500134A JP2008532967A (ja) 2005-03-10 2006-03-10 カンナビノイド受容体結合化合物のマイクロエマルジョン
US11/908,216 US20080279940A1 (en) 2005-03-10 2006-03-10 Microemulsions of Cannabinoid Receptor Binding Compounds
PCT/EP2006/002245 WO2006094829A1 (en) 2005-03-10 2006-03-10 Microemulsions of cannabinoid receptor binding compounds
EP09151789A EP2065033A1 (en) 2005-03-10 2006-03-10 Microemulsions of cannabinoid receptor binding compounds
RU2007137182/15A RU2007137182A (ru) 2005-03-10 2006-03-10 Микроэмульсии соединений, связывающихся с каннабиноидными рецепторами
CA002599251A CA2599251A1 (en) 2005-03-10 2006-03-10 Microemulsions of cannabinoid receptor binding compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0504950.7A GB0504950D0 (en) 2005-03-10 2005-03-10 Organic compositions

Publications (1)

Publication Number Publication Date
GB0504950D0 true GB0504950D0 (en) 2005-04-20

Family

ID=34508852

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0504950.7A Ceased GB0504950D0 (en) 2005-03-10 2005-03-10 Organic compositions

Country Status (12)

Country Link
US (1) US20080279940A1 (cg-RX-API-DMAC10.html)
EP (3) EP2305215A1 (cg-RX-API-DMAC10.html)
JP (1) JP2008532967A (cg-RX-API-DMAC10.html)
KR (1) KR20070117578A (cg-RX-API-DMAC10.html)
CN (1) CN101137348A (cg-RX-API-DMAC10.html)
AU (1) AU2006222117B2 (cg-RX-API-DMAC10.html)
BR (1) BRPI0609023A2 (cg-RX-API-DMAC10.html)
CA (1) CA2599251A1 (cg-RX-API-DMAC10.html)
GB (1) GB0504950D0 (cg-RX-API-DMAC10.html)
MX (1) MX2007011016A (cg-RX-API-DMAC10.html)
RU (1) RU2007137182A (cg-RX-API-DMAC10.html)
WO (1) WO2006094829A1 (cg-RX-API-DMAC10.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011513278A (ja) * 2008-02-28 2011-04-28 ノバルティス アーゲー カンナビノイド受容体結合化合物およびオピオイドを含む組合せ
JO3337B1 (ar) 2010-12-13 2019-03-13 Debiopharm Sa تركيبات صيدلية تشمل أليسبوريفير
US10350165B2 (en) * 2014-12-12 2019-07-16 Ojai Energetics Pbc Methods and systems for forming stable droplets
CA2970651C (en) * 2014-12-12 2020-09-29 Ojai Energetics Pbc Microencapsulated cannabinoid compositions
GB2551986A (en) 2016-07-01 2018-01-10 Gw Res Ltd Parenteral formulations
GB2551987A (en) 2016-07-01 2018-01-10 Gw Res Ltd Oral cannabinoid formulations
IL248149B (en) * 2016-09-29 2020-03-31 Garti Nissim Dilutable formulations of cannbinoids and processes for their preparation
IL248148B (en) 2016-09-29 2021-09-30 Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd A method for extracting a compound from plant origin
IL248150B (en) * 2016-09-29 2018-05-31 Garti Nissim Method for selective extraction of cannabinoids from a plant source
GB2559774B (en) 2017-02-17 2021-09-29 Gw Res Ltd Oral cannabinoid formulations
GB2569961B (en) 2018-01-03 2021-12-22 Gw Res Ltd Pharmaceutical
CA3264785A1 (en) 2022-08-12 2024-02-15 Jazz Pharmaceuticals Research Uk Limited ORAL SOLID DOSAGE FORMS CONTAINING CANNABINOIDS

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1274354A (fr) 1956-03-10 1961-10-27 Agents tensio-actifs obtenus à partir de triglycérides et polyéthylène glycol
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
GB9113872D0 (en) 1991-06-27 1991-08-14 Sandoz Ag Improvements in or relating to organic compounds
FR2697040B1 (fr) 1992-10-21 1994-12-30 Ind Entreprise Elément de protection contre le bruit et son utilisation.
MY129435A (en) * 1994-10-26 2007-04-30 Novartis Ag Pharmaceutical microemulsion preconcentrates
US6294192B1 (en) * 1999-02-26 2001-09-25 Lipocine, Inc. Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
GB0012795D0 (en) * 2000-05-25 2000-07-19 Novartis Ag Organic compounds
US6623765B1 (en) * 2000-08-01 2003-09-23 University Of Florida, Research Foundation, Incorporated Microemulsion and micelle systems for solubilizing drugs
GB0028702D0 (en) * 2000-11-24 2001-01-10 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
KR20070117578A (ko) 2007-12-12
AU2006222117A1 (en) 2006-09-14
EP2305215A1 (en) 2011-04-06
WO2006094829A1 (en) 2006-09-14
MX2007011016A (es) 2007-09-26
JP2008532967A (ja) 2008-08-21
CA2599251A1 (en) 2006-09-14
RU2007137182A (ru) 2009-10-20
US20080279940A1 (en) 2008-11-13
BRPI0609023A2 (pt) 2010-01-12
EP1858484A1 (en) 2007-11-28
AU2006222117B2 (en) 2010-06-03
CN101137348A (zh) 2008-03-05
EP2065033A1 (en) 2009-06-03

Similar Documents

Publication Publication Date Title
IL191572A0 (en) Pestcidal compositions
IL186721A0 (en) Bioenhanced compositions
GB0515026D0 (en) Organic compounds
GB0503337D0 (en) Compositions
IL186093A0 (en) Lignan-containing compositions
GB0500435D0 (en) Organic compounds
GB0500785D0 (en) Organic compounds
GB0502358D0 (en) Organic compounds
GB0526283D0 (en) Compositions
GB0503646D0 (en) Organic compounds
GB0501365D0 (en) Compositions
GB0504194D0 (en) Organic compounds
GB0524128D0 (en) Compositions
GB0504544D0 (en) Organic compounds
GB0501237D0 (en) Organic compounds
GB0500784D0 (en) Organic compounds
GB0504203D0 (en) Organic compounds
GB0500020D0 (en) Organic compounds
GB0500683D0 (en) Organic compounds
ZA200709913B (en) Bioenhanced compositions
GB0526282D0 (en) Compositions
GB0624857D0 (en) Organic composition
GB0514684D0 (en) Organic compounds
GB0521725D0 (en) Organic compounds
GB0508435D0 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)